1. Home
  2. SENS vs INGN Comparison

SENS vs INGN Comparison

Compare SENS & INGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Senseonics Holdings Inc.

SENS

Senseonics Holdings Inc.

HOLD

Current Price

$5.94

Market Cap

213.2M

Sector

Industrials

ML Signal

HOLD

Logo Inogen Inc

INGN

Inogen Inc

HOLD

Current Price

$6.55

Market Cap

172.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SENS
INGN
Founded
1996
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Industrial Specialties
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
213.2M
172.4M
IPO Year
2014
2013

Fundamental Metrics

Financial Performance
Metric
SENS
INGN
Price
$5.94
$6.55
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
4
Target Price
$18.38
$11.25
AVG Volume (30 Days)
995.5K
315.0K
Earning Date
05-08-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
43.42
EPS
N/A
N/A
Revenue
$16,389,000.00
$348,668,000.00
Revenue This Year
$74.15
$8.03
Revenue Next Year
$58.60
$7.76
P/E Ratio
N/A
N/A
Revenue Growth
19.85
3.86
52 Week Low
$0.41
$5.34
52 Week High
$8.75
$9.13

Technical Indicators

Market Signals
Indicator
SENS
INGN
Relative Strength Index (RSI) 46.62 43.16
Support Level $5.41 $5.97
Resistance Level $8.55 $6.93
Average True Range (ATR) 0.46 0.37
MACD -0.12 -0.05
Stochastic Oscillator 41.92 13.08

Price Performance

Historical Comparison
SENS
INGN

About SENS Senseonics Holdings Inc.

Senseonics Holdings Inc is a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system to improve the lives of people with diabetes by enhancing their ability to manage their disease with relative ease and accuracy. Its implantable CGM system, Eversense, including Eversense E3 and Eversense 365 CGM systems, measures glucose levels via an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company operates through one reportable segment which derives its revenues from diabetes products and services and generates the majority of its revenue from the United States.

About INGN Inogen Inc

Inogen Inc is a medical technology business that focuses on respiratory health. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. In addition, it has started distributing the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure, or CPAP, masks in the United States. The company derives revenues from customers through the development, manufacturing, marketing, sales, and rental of respiratory products.

Share on Social Networks: